For the first time, the prejudice of anxiety has been recognized by the courts for 12 consumers of the Mediator. On the other hand, 38 users were unsuccessful.
They are not sick because of the Mediator but smell the sword of Damocles. An anguish recognized today by justice. This Thursday, the tribunal de grande instance (TGI) recognized the prejudice of anxiety for 12 plaintiffs. A first in the Mediator scandal. However, 38 people were unsuccessful due to lack of evidence. They could appeal.
In 3 decisions, the summary judges of the Nanterre TGI ordered the manufacturer and the Servier laboratories to pay 1,500 euros in provisions for compensation for the prejudice of anxiety to the 12 consumers. At the hearing on December 8, 2015, the 50 plaintiffs each claimed 15,000 euros in provisions. A decision that displeases Servier laboratories. They have made it known that they could appeal.
Responsible for over 2,000 deaths
Used by 5 million people in France, this anti-diabetic was widely used as an appetite suppressant for more than 30 years before being withdrawn from the French market in November 2009. Mediator (benfluorex) is at the origin of serious lesions of the skin. heart valves (valve disease) and pulmonary arterial hypertension (PAH), a rare and incurable pathology. According to the medical literature, the risk of heart valve disease disappears 2 years after stopping treatment. But there is no data to conclude for PAH.
According to a forensic expert opinion, this drug could be responsible in the long term for the death of 2,100 people.
.
